| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lansoprazole | FAERS: 2 | US FAERS | |
| 2 | Clopidogrel | FAERS: 1 | US FAERS | |
| 3 | Isotretinoin | FAERS: 1 | US FAERS | |
| 4 | Norgestrel | FAERS: 1 | US FAERS | |
| 5 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 6 | Tacrolimus | FAERS: 1 | US FAERS | |
| 7 | apixaban | FAERS: 1 | US FAERS | |
| 8 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 9 | rofecoxib | FAERS: 1 | OFFSIDES US FAERS | |
| 10 | Glatiramer Acetate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120267
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.